Filing Details
- Accession Number:
- 0001714899-21-000117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-30 21:59:44
- Reporting Period:
- 2021-12-28
- Accepted Time:
- 2021-12-30 21:59:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1714899 | Denali Therapeutics Inc. | DNLI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1437435 | Marc Tessier-Lavigne | C/O Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-10-04 | 300,000 | $0.00 | 2,244,370 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2021-10-04 | 100,000 | $0.00 | 100,000 | No | 5 | G | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| Common Stock | Disposition | 2021-12-28 | 3,732 | $44.37 | 96,268 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| Common Stock | Disposition | 2021-12-29 | 10,700 | $43.88 | 85,568 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| Common Stock | Disposition | 2021-12-30 | 3,343 | $45.13 | 82,225 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| Common Stock | Disposition | 2021-12-30 | 3,377 | $45.59 | 78,848 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| Common Stock | Acquisiton | 2021-10-04 | 100,000 | $0.00 | 100,000 | No | 5 | G | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| Common Stock | Disposition | 2021-12-28 | 3,602 | $44.38 | 96,398 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| Common Stock | Disposition | 2021-12-29 | 10,700 | $43.87 | 85,698 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| Common Stock | Disposition | 2021-12-30 | 5,625 | $45.31 | 80,073 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| Common Stock | Disposition | 2021-12-30 | 900 | $45.71 | 79,173 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| Common Stock | Acquisiton | 2021-10-04 | 100,000 | $0.00 | 100,000 | No | 5 | G | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
| Common Stock | Disposition | 2021-12-28 | 3,646 | $44.37 | 96,354 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
| Common Stock | Disposition | 2021-12-29 | 10,704 | $43.88 | 85,650 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
| Common Stock | Disposition | 2021-12-30 | 6,002 | $45.31 | 79,648 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
| Common Stock | Disposition | 2021-12-30 | 800 | $45.72 | 78,848 | No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| No | 5 | G | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| No | 5 | G | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
| No | 4 | S | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
Footnotes
- This transaction involved a gift of securities by the Reporting Person. Disposition price is not applicable as this transaction was a bona fide gift.
- Includes 2,074 restricted stock units.
- The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person serves as trustee.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.19 to $44.74 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $43.50 to $44.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.42 to $45.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $45.42 to $45.81 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person serves as trustee.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.19 to $44.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $43.51 to $44.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.65 to $45.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $45.66 to $45.77 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person serves as trustee.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.18 to $44.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $43.50 to $44.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.65 to $45.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $45.67 to $45.80 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
